Clinical Research for Application of N-acetylcysteine in Children with Pneumonia and SIRS

ZHU Wei-dong,ZHU Cui-ping,YAN Jian-jiang,MA Wen-cheng,JIANG Jian-min,LI Jia-hua
2010-01-01
Journal of Tropical Medicine
Abstract:Objective To investigate the role of N-acetylcysteine(NAC) in pneumonia therapy and prophylaxis of systemic inflammatory response syndrome(SIRS) in children.Methods Two groups were studied:control and NAC.Plasma levels of interleukin-1(IL-1),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),alanine aminotransferase(ALT),aspartate aminotransferase(AST) and creatinine(CR) were determined.Sings and symptoms were observed and recorded.Results Total effective rate was higher in the NAC group as compared with the control group(P0.05).Hospitalization day(HOD) in the NAC group was less than the control group.Effectiveness was non-specific between the two groups at clinical stageⅠ,Ⅱand Ⅴ,but higher in the NAC group at clinical stage Ⅲ and Ⅳ.Plasma levels of IL-6,TNF-α,ALT and CR were decreased post-treatment in both NAC and control group,but decreased obviously in the NAC group(P0.01).Conclusions Application of NAC early in children with pneumonia could lessen the organ damage caused by inflammatory reaction,and shorten the hospitalization day.Because of regulating the level of inflammatory factor such as IL-6,TNF-α etc.NAC might interfere the proceeding of multiorgan dysfunction syndrome(MODS)induced by SIRS,and reduce the incidence of MODS.
What problem does this paper attempt to address?